I’ve Been Watching This One for Years. I Just Pulled the Trigger.

Bold Bets on Category-Defining Companies

There are ideas you follow. And then there are ideas you own. The difference between the two is not information. It is conviction. And conviction, as I have said before, cannot be borrowed. It is built slowly, through repeated verification, through sitting with an idea long enough to understand it at its core, through watching the clinical evidence accumulate, the financial inflections arrive, and the thesis strengthen quarter by quarter while the market is looking somewhere else.

I have been following this company for years. I wrote about it twice. I watched it closely. I waited. This week I stopped waiting. I initiated a new position. It is now the No 3. holding in my portfolio, behind Oscar Health and Mercado Libre.

The hook today is simple. One of the greatest investors alive — a man who ran George Soros’s Quantum Fund for 14 years without a single down year and averaged 30% annual returns across his career — just added significantly to this position in Q1 2026.

I am not a follower. But when someone of that caliber keeps adding to the same thesis I have been building independently, it reinforces what the research already told me. I finally pulled the trigger

The name of this company and the full position rationale are exclusively for paid members of FJ Research. I have written about this company twice before. Both reports are linked below for paid subscribers — follow the development of this thesis from the beginning. $49 a year. 13 cents a day. Subscribe now.

Paid subscribers: the full update continues below. My two earlier reports on this company are linked at the bottom of this post — I encourage you to read them in sequence to see how this thesis developed.